US 12084436
Heterocyclic compound
granted A61KA61K31/4245A61K31/427
Quick answer
US patent 12084436 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/4245, A61K31/427, A61K31/437, A61K31/4375